How Do Wegovy and Mounjaro Mechanisms Actually Differ?
What Is Wegovy Injection: The Key Differences from Mounjaro
When exploring what is Wegovy injection compared to Mounjaro, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single natural fullness hormone in your body. Mounjaro (tirzepatide) is a dual-action medication targeting both GLP-1 and GIP receptors, offering a different approach to appetite regulation.
Understanding what is Wegovy injection means recognising its targeted approach through the GLP-1 pathway alone. This focused mechanism has been extensively studied in clinical trials, with the STEP programme demonstrating significant weight management results when used alongside a reduced-calorie diet and increased physical activity. Mounjaro's dual-receptor approach represents a newer strategy, though both remain prescription-only medicines requiring clinical assessment.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
At EverydayMeds, we offer transparent pricing for both treatments, making it easier to understand what is Wegovy injection going to cost compared to Mounjaro. Wegovy single pens range from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose, with discount codes FIRST40 (new customers) and DOSE25 (returning customers) applied at checkout. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99.
Mounjaro pricing follows a similar structure but with different dose escalation requirements across six dose levels (2.5mg to 15mg) compared to Wegovy's five doses (0.25mg to 2.4mg). Both treatments require gradual dose increases, but Mounjaro's higher maximum dose means potentially longer escalation periods. Your prescriber can help determine which dosing schedule aligns better with your treatment goals and budget considerations.
Clinical Evidence: What Is Wegovy Injection's Track Record vs Mounjaro
The STEP clinical trial programme provides extensive evidence for what is Wegovy injection capable of achieving. In clinical trials, patients taking Wegovy alongside diet and exercise experienced an average of ~clinically studied weight loss at 68 weeks in STEP 1, compared to ~2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT trial also demonstrated a 20% reduction in major cardiovascular events, highlighting potential health benefits beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, though direct head-to-head comparisons between the treatments haven't been conducted due to different trial designs. Both medications have received MHRA approval for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, demonstrating their established efficacy profiles when used as prescribed.
How Wegovy Works: Understanding the GLP-1 Mechanism
When people ask what is Wegovy injection, they're inquiring about a sophisticated treatment that works on your body's natural appetite regulation system. Wegovy is a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. This hormone signals to your brain that you're full, helping to reduce appetite and food cravings. The medication works by slowing gastric emptying, meaning food stays in your stomach longer, promoting prolonged feelings of satiety. Additionally, Wegovy may influence the brain's appetite centres directly, potentially reducing the psychological urge to eat between meals.
Simple Ordering Process: From Assessment to Delivery
Getting started with either Wegovy or Mounjaro through EverydayMeds follows a streamlined process designed for convenience and safety. Complete our 3-minute online clinical assessment, providing information about your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), determining suitability and appropriate starting doses. Once approved, your prescription-only medicine is dispatched via next-day delivery using temperature-controlled packaging to maintain medication integrity. All treatments are sourced from our GPhC-registered pharmacy (#9012878), ensuring pharmaceutical-grade quality and proper cold-chain handling throughout the supply process.
Storage and Practical Considerations for Daily Use
A key practical difference when considering what is Wegovy injection involves storage requirements compared to Mounjaro. Wegovy pens must be stored in the refrigerator at 2–8°C before first use, but once removed, they can remain at room temperature (below 30°C) for up to 6 weeks. This provides significant flexibility for travel, work schedules, or situations where refrigerated storage isn't immediately available. Mounjaro, by contrast, can only survive 21 days at room temperature once removed from refrigeration. Both medications use pre-filled FlexTouch pens for once-weekly injection, typically administered in the thigh, abdomen, or upper arm on the same day each week.
What Is Wegovy Injection vs Mounjaro for Different Patient Profiles
The choice between treatments often depends on individual circumstances and medical history. Wegovy's single-pathway GLP-1 approach may suit patients seeking a well-established mechanism with extensive long-term data, particularly given the cardiovascular outcomes evidence from SELECT. The medication's superior room temperature storage also benefits frequent travellers or those with unpredictable schedules.
Mounjaro's dual GIP/GLP-1 mechanism might appeal to patients and prescribers interested in the newest treatment approaches, though this means less long-term real-world data. The different dose escalation schedules also create varying treatment timelines, with some patients reaching therapeutic doses sooner with one medication versus the other, depending on tolerance and response patterns.
Making Your Choice: Expert Guidance and Next Steps
Understanding what is Wegovy injection compared to Mounjaro ultimately requires personalised medical guidance that considers your unique health profile. At EverydayMeds, we provide access to both treatments through the same trusted pathway, eliminating the need to compare different providers or pharmacy standards. Use discount code FIRST40 for new customers or DOSE25 for returning customers at checkout to access our competitive pricing structure. Our clinical team ensures both treatments meet the same rigorous pharmaceutical standards, with proper cold-chain storage and next-day delivery nationwide. Whether your prescriber recommends Wegovy's proven GLP-1 approach or Mounjaro's innovative dual-receptor mechanism, you can proceed with confidence knowing both options are available through our weight loss collection with comprehensive support throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
